4.6 Article

CPIC: Clinical Pharmacogenetics Implementation Consortium of the Pharmacogenomics Research Network

Journal

CLINICAL PHARMACOLOGY & THERAPEUTICS
Volume 89, Issue 3, Pages 464-467

Publisher

WILEY
DOI: 10.1038/clpt.2010.279

Keywords

-

Funding

  1. National Institutes of Health's (National Institute of General Medical Sciences, National Institute of Child Health and Human Development, and National Cancer Institute) Pharmacogenomics Research Network (PGRN) [PAAR4Kids (UO1 GM92666), P30 CA21765, PharmGKB (R24 GM61374)]
  2. ALSAC

Ask authors/readers for more resources

The slow rate at which pharmacogenetic tests are being adopted in clinical practice is partly due to the lack of specific guidelines on how to adjust medications on the basis of the genetic test results. One of the goals of the Clinical Pharmacogenetics Implementation Consortium (CPIC) of the National Institutes of Health's Pharmacogenomics Research Network (http://www.pgrn.org) and the Pharmacogenomics Knowledge Base (PharmGKB, http://www.pharmgkb.org) is to provide peer-reviewed, updated, evidence-based, freely accessible guidelines for gene/drug pairs. These guidelines will facilitate the translation of pharmacogenomic knowledge from bench to bedside.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.6
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available